Evidence map›Paper›PMID 27571515›Full record

ArticlePloS one2016

Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.

Zainab Ali, Houda Harastani, Moza Hammadi, Lina Reslan, Soha Ghanem, Farah Hajar, Ahmad Sabra, Amjad Haidar, Adlette Inati, Mariam Rajab and 7 more

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Epidemiological, molecular, and clinical features of rotavirus infections among pediatrics in Qatar.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  13. Article
  14. Article
  15. Full genome characterization of human G3P[6] and G3P[9] rotavirus strains in Lebanon.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Zainab AliDepartment of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Houda HarastaniCenter for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Moza HammadiDepartment of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Lina ReslanCenter for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Soha GhanemDepartment of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Farah HajarDepartment of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Ahmad SabraCenter for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Amjad HaidarCenter for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Adlette InatiDepartment of Pediatrics, Nini Hospital, Tripoli, Lebanon.
Mariam RajabDepartment of Pediatrics, Makassed General Hospital, Beirut, Lebanon.
Hassan FakhouriDepartment of Pediatrics, Rafic Hariri University Hospital, Beirut, Lebanon.
Bassam GhanemDepartment of Pediatrics, Nabatieh Governmental Hospital, Nabatieh, Lebanon.
Ghassan BaasiriDepartment of Pediatrics, Hammoud Hospital, Saida, Lebanon.
Bernard GerbakaDepartment of Pediatrics, Hôtel-Dieu de France University Hospital, Beirut, Lebanon.
Hassan ZaraketCenter for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Ghassan M MatarCenter for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Ghassan DbaiboDepartment of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGlobally, rotavirus (RV) is the leading cause of gastroenteritis (GE) in children. Longitudinal data about changes in RV genotype distribution and vaccine effectiveness (VE) are scarce. This study was conducted in Lebanon over 3 consecutive RV seasons to estimate the rate of RVGE hospitalization, identify RV genotypes, determine the seasonal and geographical variations, and calculate RV VE. MATERIALS AND

methodsThis prospective, multicenter, hospital-based surveillance study was conducted between 2011 and 2013 and enrolled children (<5 years) admitted for GE. Socio-demographic and clinical data about the current episode of GE at admission were collected. Genotypes were determined from stool samples testing positive for RV by PCR.

resultsOf 1,414 cases included in the final analysis, 83% were <2 years old and 55.6% were boys. Median duration of hospitalization was 4 days and 91.6% of GE cases were severe (Vesikari score ≥11). PCR testing showed that 30.3% of subjects were RV-positive of which 62.1% had fever versus 71.1% of RV-negative subjects (P = 0.001). RV was predominantly detected in the cold season from November till March (69.9%). G and P genotype pairs for all RV-positive stool specimens showed a predominance of G1P[8] in 36% (n = 154) of specimens, G9P[8] in 26.4% (n = 113), and G2P[4] in 17.8% (n = 76). RV-negative subjects were more likely to be RV-vaccinated (21%) compared to the RV-positive subjects (11.3%) (P<0.001), with a vaccine breakthrough rate of 18.8%. The ratio of RV1-vaccinated for each RV5-vaccinated subject was 7.8 and VE against RV disease was 68.4% (95%CI, 49.6%-80.2%).

conclusionRV is a major cause of GE requiring hospitalization of children under 5 years of age in Lebanon. A few genotypes predominated over the three RV seasons studied. Mass RV vaccination will likely decrease the burden of hospitalization due to RV. VE is similar to what has been observed for other middle-income countries.

Indexed as

Child, PreschoolFemaleGenotypeHospitalsHumansInfantInfant, NewbornLebanonMaleProspective StudiesRotavirusRotavirus InfectionsRotavirus VaccinesSeasonsRotavirus Vaccines

Identifiers

PMID27571515
PMCPMC5003350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.